Maria Libera Ascierto

Professor Translational Cancer Immunology; Head Clinical Biomarkers@School of Cancer Sciences, University of Glasgow

[Maria Libera Ascierto @MLAscierto]

Excited to see this work now online. Congrats to all Providence SJCI team involved 👏 https://t.co/pfqdkz8nJ6

[Maria Libera Ascierto @MLAscierto]

Excited to see this paper out from my former team at Providence Health Center in Santa Monica. Very good work and congratulations to All 🎉👏💪🏻https://t.co/iiTOtZfwSl

[Maria Libera Ascierto @MLAscierto]

@ProfRScolyerMIA @JWilmott38 @inespiresilva @amenzies9 @MattCarlino @syd_health @CPC_usyd @SHPartners @SydneyResearch @SydneyCatalyst @PathologyRCPA This is fantastic news. Very happy for you

[Maria Libera Ascierto @MLAscierto]

@Gino_K_In_USC @kmargolin @arivanderw @GeoffGibney @LutzkyJose @lab_ito @FrancesChowMD @DoctorZada @LHwangMD Congratulations for leading this very important effort. Thanks to you and Caris team for letting me be part of it.

[Maria Libera Ascierto @MLAscierto]

@DrBetofMDPhD @RZappasodi @WCM_MeyerCancer Go @RZappasodi !!!

[Maria Libera Ascierto @MLAscierto]

Congratulations to Dr Kim Margolin, for this very much deserved award. Thank you, Dr Margolin for all what you have done for patients and for the immunotherapy field.

[Maria Libera Ascierto @MLAscierto]

@HTawbi_MD @DrSapnaPatel Congrats !

[Maria Libera Ascierto @MLAscierto]

Wonderful melanoma Symposium with great talks. Thanks to the organizers for the invitation https://t.co/x5ZtnRpZeF

[Maria Libera Ascierto @MLAscierto]

@rbryanbell @BernardAFox Happy bday Bernie!

[Maria Libera Ascierto @MLAscierto]

Proud and honored to speak at the 2nd Melanoma Symposium in Santa Monica this coming Saturday, April 29th 2023- Register below and plan to attend! Melanoma Symposium - Saint John’s Cancer Institute (https://t.co/7KTAi7tKrs)

[Maria Libera Ascierto @MLAscierto]

Next generation immuno-oncology strategies: Unleashing NK cells activity, is now available online. Thanks to the team for this solid work and happy reading. https://t.co/9E924Of3b7

[ProvidenceCalifornia @ProvCalifornia]

A #Melanoma Symposium https://t.co/QHb5h9cdll
Join @EssnerRick @kmargolin @MLAscierto
Sat April 30 @FairmontHotels Santa Monica
@vernonsondak @jasonlukemd @alliegrossman @DrSancy
@drsapnapatel @drtrevanfischer @stevenkolkermd & Drs.Ron Korn, Dave Hoon, Patrick Ott

[Allison Betof, MD, PhD, FASCO @DrBetofMDPhD]

PRACTICE CHANGING news in #uveal #melanoma. @FDAOncology approved tebentafusp for advanced uveal melanoma. This is huge- first drug to show OS benefit in this patient population! Thanks to the patients who participated in this trial and congrats to the investigators! @OncoAlert

[Cancer Discovery @CD_AACR]

From the Nov. issue: Resistance to durvalumab and durvalumab plus tremelimumab is associated with functional #STK11 mutations in non-small-cell #lungcancer patients and is reversed by STAT3 knockdown. https://t.co/tVWXlYsK7X
@nabendu71 @MLAscierto et. al @AstraZeneca

[Omid Hamid MD @OmidHamidMD]

Congrats to @Immunocore for @NEJM publication Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma. Proud to be part of this program and its success for our patients
#clinicaltrials @angelesclinic
https://t.co/jqg525hZwk

[Maria Libera Ascierto @MLAscierto]

I cannot be more honored and proud to lead this journey at SJCI https://t.co/raKzPUsDRl

[Nick Haining @nickhaining]

Can't escape T cell exhaustion in the latest @NatImmunol, with a triptych of papers from: @DebattamaSen @EJohnWherry, Georg Lauer and a great N&V explainer from @Hazemghoneim11
https://t.co/hyT8nc1WSq [1/n]

[Maria Libera Ascierto @MLAscierto]

Priceless tips shared by key immunotherapy leaders during WIN leadership Institute workshop. https://t.co/V19NLd1BjM.
#leadershipdevelopment #coaching #emotionalintelligence #immunotherapy

[Elizabeth McKenna @ElizSMcKenna]

Now online in @CD_AACR: Resistance to durvalumab and durvalumab plus tremelimumab is associated with functional #STK11 mutations in NSCLC and is reversed by #STAT3 knockdown, by @nabendu71 @MLAscierto and colleagues @AstraZeneca #immunotherapy https://t.co/Nzl6rFLOZq

[Maria Libera Ascierto @MLAscierto]

One Post- Doctoral Fellowship and one Flow Cytometry Specialist position are immediately available at St John’s Cancer Institute. Join my team to support the advancement of Immunology, Cancer Immunotherapy, Biomarker Discovery #immunotherapy,#immunology,#jobopening,

[SIICA Immunologia @SiicaI]

One post-doctoral fellowship and one flow cytometry position are immediately available in the Translational Cancer #Immunology Unit, Providence St John’s Cancer Institute in Santa Monica, California. If interested, send an email to [email protected]